𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intrahepatic portal cavernoma as an indication for liver transplantation

✍ Scribed by Cristina H. Hajdu; Takahiro Murakami; Thomas Diflo; Bachir Taouli; Jordan Laser; Lewis Teperman; Lydia M. Petrovic

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
324 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis

Cavernous transformation of the portal vein (portal cavernoma) consists of a periportal or/and intrahepatic venous collateral network, developed as a result of acute or long-standing portal vein thrombosis. Better control of hemorrhagic and thrombotic complications in the patients with portal cavernoma substantially improves their life span and the clinical outcome. However, biliary complications that occur in the late stages of this disease have been recently recognized as challenging management issues because they recur and are difficult to treat. Because of the relatively small number of the patients with cholangiopathy due to portal cavernoma, there is no current standardized treatment approach. We report the case of a predominantly intrahepatic portal cavernoma occurring in a patient with chronic idiopathic portal vein thrombosis, which led to severe cholangiopathy that mimicked primary sclerosing cholangitis and cholangiocarcinoma, was unresponsive to endoscopic stent placement, and finally required liver transplantation.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for severe intrahe
Liver transplantation for severe intrahepatic noncirrhotic portal hypertension
✍ Alyssa M. Krasinskas; Bijan Eghtesad; Patrick S. Kamath; Anthony J. Demetris; Su πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 356 KB

Intrahepatic noncirrhotic portal hypertension can be idiopathic or associated with known toxic, developmental, vascular, or biliary tract diseases. Most patients are successfully managed medically or with shunting procedures. The goal of this study was to explore the reasons some patients require or

Laparoscopic iatrogeny of the hepatic hi
Laparoscopic iatrogeny of the hepatic hilum as an indication for liver transplantation
✍ Juan Angel FernΓ‘ndez; Ricardo Robles; Caridad MarΓ­n; Francisco SΓ‘nchez-Bueno; Pa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

This was a primary biliary cirrhosis with an evolution accelerated by the lesion. † Pre-LT death in a patient with liver cirrhosis. ‑ Pre-LT death in an anhepatic patient awaiting a compatible graft.

Monitoring of surface mitochondrial nadh
Monitoring of surface mitochondrial nadh levels as an indication of ischemia during liver isograft transplantation
✍ Maureen S. Thorniley; Sandra Simpkin; Barry Fuller; Mandana Z. Jenabzadeh; Colin πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 962 KB

Ischemia-reperfusion injury is a major cause of transplant dysfunction. One feature of this damage is mitochondrial dysfunction. The objective of this study was to determine whether surface fluorometric measurements of mitochondrial NADH can be made, and if the technique can detect differences in mi

Portopulmonary hypertension as an indica
Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: Literature review and case presentation
✍ Nicole E. Scouras; Takashi Matsusaki; Charles D. Boucek; Cynthia Wells; Erik A. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

End-stage liver disease with severe portopulmonary hypertension (PPHTN), which is refractory to vasodilator therapies, is a contraindication for isolated liver transplantation (LT) because of the high mortality rate. Combined heart, lung, and liver transplantation (CHLLT) and combined lung and liver